Buzzard Pharmaceuticals
Pharmaceutical Manufacturing
Solna, Stockholms Län, Se
5 employees
- Employees
- 5
- Contacts
- 1
- Emails
- 1
Buzzard Pharmaceuticals Overview
- Headquarters
- Solna, Stockholms Län, Se
- Website
- www.buzzardpharma.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 5
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About Buzzard Pharmaceuticals
Buzzard Pharmaceuticals is a biopharmaceutical development company. We are developing Isunakinra, an IL-1 inhibitor for the treatment of cancer. Isunakinra (EBI-005) is a recombinant protein binding to the IL1R1 with high potency. IL-1 mediates the recruitment of immunesuppressive myeloid cells (PMN-MDSCs, neutrophils and T2 macrophages) to the tumor - that inhibit CD8 T cells from entering the tumor and killing tumor cells. Moreover, IL-1 stimulates angiogensis and tumor spread.
Buzzard Pharmaceuticals Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
Buzzard Pharmaceuticals Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Carl-Johan Spak | Senior Advisor at Flerie Invest |
View
|
|
| Mattias Häggblom | Handelsbanken | Greater Stockholm Metropolitan Area, Sweden |
Email
|
Compare Similar Companies to Buzzard Pharmaceuticals
Affibody AB
Biotechnology
Diamyd Medical
Pharmaceutical Manufacturing
Cantargia AB
Biotechnology Research
Atrogi
Pharmaceutical Manufacturing
Ascelia Pharma AB
Pharmaceutical Manufacturing
Guard Therapeutics
Biotechnology Research
Immuneed
Research Services
Abera Bioscience AB
Biotechnology Research
Key2Brain AB
Biotechnology
Sixera Pharma
Pharmaceutical Manufacturing